Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.8T | 1.6T | 2.1T | 1.9T |
Cost of revenue | 1.7T | 1.5T | 2.0T | 1.7T |
Gross profit | 113.5B | 100.5B | 131.0B | 114.7B |
Operating expense | ||||
Research & development | 30.2B | 26.6B | 34.1B | 29.2B |
Selling general and admin | 26.7B | 27.4B | 32.4B | 30.8B |
Other operating expenses | — | — | — | — |
Operating income | 56.6B | 46.5B | 64.5B | 54.8B |
Non operating interest income | ||||
Income | 7.7B | 8.1B | 9.6B | 8.8B |
Expense | 8.7B | 7.5B | 8.1B | 8.8B |
Other income expense | — | — | — | — |
Pretax income | 65.1B | 59.1B | 63.3B | 67.7B |
Tax provision | 15.6B | 13.3B | 10.8B | 12.3B |
Net income | 49.5B | 45.8B | 52.5B | 55.3B |
Basic EPS | 3.2 | 3.0 | — | 3.6 |
Diluted EPS | 3.2 | 3.0 | — | 3.5 |
Basic average shares | 13.9B | 13.9B | — | 13.9B |
Diluted average shares | 14.0B | 14.1B | — | 14.0B |
EBITDA | 97.4B | 90.2B | 97.9B | 98.0B |
Net income from continuing op. | 65.1B | 59.1B | 63.3B | 67.7B |
Minority interests | -5.2B | -3.7B | -6.2B | -6.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |